These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 29029488)
1. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma. Sui J; Xu SY; Han J; Yang SR; Li CY; Yin LH; Pu YP; Liang GY Oncotarget; 2017 Sep; 8(39):65997-66018. PubMed ID: 29029488 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177 [TBL] [Abstract][Full Text] [Related]
3. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network. Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871 [TBL] [Abstract][Full Text] [Related]
4. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy. Hu J; Xu L; Shou T; Chen Q Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498 [TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma. Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625 [TBL] [Abstract][Full Text] [Related]
7. Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network. Qi L; Zhang T; Yao Y; Zhuang J; Liu C; Liu R; Sun C PeerJ; 2019; 7():e7727. PubMed ID: 31576252 [TBL] [Abstract][Full Text] [Related]
8. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma. Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143 [TBL] [Abstract][Full Text] [Related]
9. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma. Huang H; Wu W; Lu Y; Pan X J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308 [TBL] [Abstract][Full Text] [Related]
10. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis. Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351 [TBL] [Abstract][Full Text] [Related]
11. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
12. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma. Tang RX; Chen WJ; He RQ; Zeng JH; Liang L; Li SK; Ma J; Luo DZ; Chen G Oncotarget; 2017 Aug; 8(31):50761-50773. PubMed ID: 28881601 [TBL] [Abstract][Full Text] [Related]
13. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Li X; Li B; Ran P; Wang L Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725 [TBL] [Abstract][Full Text] [Related]
14. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma. Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688 [TBL] [Abstract][Full Text] [Related]
15. Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets. Ning P; Wu Z; Hu A; Li X; He J; Gong X; Xia Y; Shang Y; Bian H PeerJ; 2018; 6():e4254. PubMed ID: 29340250 [TBL] [Abstract][Full Text] [Related]
16. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma. Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748 [TBL] [Abstract][Full Text] [Related]
17. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma. Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486 [TBL] [Abstract][Full Text] [Related]
18. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma. Liu B; Chen Y; Yang J Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma. Yao N; Zuo L; Yan X; Qian J; Sun J; Xu H; Zheng F; Efird JT; Kawagoe I; Wang Y; Ni S Transl Lung Cancer Res; 2022 Apr; 11(4):632-646. PubMed ID: 35529787 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma. Liu N; Liu Z; Liu X; Chen H Front Oncol; 2019; 9():935. PubMed ID: 31649871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]